2/9
08:00 am
vrca
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
Medium
Report
Verrica Pharmaceuticals Announces Launch of YCANTH® for the Treatment of Molluscum Contagiosum in Japan by Partner Torii Pharmaceutical
2/7
02:07 am
vrca
Verrica Pharmaceuticals (NASDAQ:VRCA) was downgraded by analysts at
Wall
Medium
Report
Verrica Pharmaceuticals (NASDAQ:VRCA) was downgraded by analysts at
Wall
1/17
01:11 am
vrca
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at
Wall S
Medium
Report
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at
Wall S
1/13
05:44 am
vrca
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/7
05:01 pm
vrca
Verrica Pharmaceuticals (NASDAQ:VRCA) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Verrica Pharmaceuticals (NASDAQ:VRCA) had its "buy" rating reaffirmed by analysts at Cowen Inc.
1/7
08:00 am
vrca
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
Low
Report
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
12/18
08:05 am
vrca
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Brookline Capital Management from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock.
Low
Report
Verrica Pharmaceuticals (NASDAQ:VRCA) was upgraded by analysts at Brookline Capital Management from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock.
12/18
08:03 am
vrca
Verrica Pharmaceuticals (NASDAQ:VRCA) was given a new $17.00 price target on by analysts at Loop Capital.
Low
Report
Verrica Pharmaceuticals (NASDAQ:VRCA) was given a new $17.00 price target on by analysts at Loop Capital.
11/24
08:00 am
vrca
Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway
Low
Report
Verrica Pharmaceuticals Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway
11/14
05:27 pm
vrca
Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/14
04:54 pm
vrca
Verrica Pharmaceuticals Non-GAAP EPS of $0.13, revenue of $14.3M [Seeking Alpha]
Medium
Report
Verrica Pharmaceuticals Non-GAAP EPS of $0.13, revenue of $14.3M [Seeking Alpha]
11/14
04:05 pm
vrca
Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results
Medium
Report
Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results